首页> Molecular cancer therapeutics> Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine Kinase.

Targeting Casein Kinase 1 Delta Sensitizes Pancreatic and Bladder Cancer Cells to Gemcitabine Treatment by Upregulating Deoxycytidine Kinase.

导出 OA

翻译打印收藏纠错

第一作者： Francesca,Vena

第一单位： Department of Drug Discovery, Moffitt Cancer Center, Tampa, Florida.

作者： Francesca,Vena ^[1] ; Simon,Bayle ^[1] ; Ainhoa,Nieto ^[2] ; Victor,Quereda ^[1] ; Massimiliano,Aceti ^[1] ; Sylvia M,Frydman ^[1] ; Samer S,Sansil ^[3] ; Wayne,Grant ^[4] ; Andrii,Monastyrskyi ^[1] ; Patricia,McDonald ^[2] ; William R,Roush ^[4] ; Mingxiang,Teng ^[5] ; Derek,Duckett ^[6]

作者单位： Department of Drug Discovery, Moffitt Cancer Center, Tampa, Florida. ^[1] Department of Cancer Physiology, Moffitt Cancer Center, Tampa, Florida. ^[2] Translational Research Core, Moffitt Cancer Center, Tampa, Florida. ^[3] Department of Chemistry, The Scripps Research Institute, Jupiter, Florida. ^[4] Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida. ^[5] Department of Drug Discovery, Moffitt Cancer Center, Tampa, Florida. derek.duckett@moffitt.org. ^[6]